<DOC>
	<DOCNO>NCT01120327</DOCNO>
	<brief_summary>1 . OBJECTIVES Primary objective evaluate difference peak oxygen uptake change ( VO2 max , mL/kg/min ) amlodipine group CCB group 9 month Secondary objective To evaluate change sublingual nitrate use per day CCB group 1 3 month To evaluate change biomarkers CCB group 9 month 2 . SUBJECTS AND CENTERS 212 , stable angina patient angiographically confirm significant residual stenosis 10 , 3rd-grade , teach hospital Korea</brief_summary>
	<brief_title>A Pilot Study Exploring Efficacy Safety Amlodipine Stented Angina Patients</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Stable angina patient angiographically confirm significant residual stenosis Stenosis 50 % 2 major coronary artery least Stenosis 75 % 1 major coronary artery No pulmonary/psychiatry/musculoskeletal disorder limit CPET Contraindicated CPET ( e.g . unstable angina , aortic stenosis , uncontrolled hypertension , uncontrolled asthma , hypoxemia rest , epilepsy , locomotor disorder , severe hypertension febrile illness )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2010</verification_date>
</DOC>